Art Therapy for Caregivers of Young Patients Undergoing Bone Marrow Transplant for Cancer

NCT ID: NCT00922285

Last Updated: 2015-06-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

11 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-06-30

Study Completion Date

2010-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

RATIONALE: Art therapy may help relieve emotional distress in caregivers of young patients undergoing bone marrow transplant for cancer.

PURPOSE: This clinical trial is studying art therapy for caregivers of young patients undergoing bone marrow transplant for cancer.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

OBJECTIVES:

* Test the effects of an art therapy intervention on emotional distress in caregivers of pediatric patients undergoing bone marrow transplantation for cancer.
* Describe pro-social interactions of caregivers of pediatric patients undergoing bone marrow transplantation for cancer.
* Describe the illness experience of caregivers and how it is impacted by the art therapy intervention.
* Describe the caregivers' current health-related quality of life and life meaning prior to pediatric patients initiation of bone marrow transplantation for cancer.
* Determine the effect size for calculating the sample needed for a randomized clinical trial.

OUTLINE: Caregivers undergo art therapy over 60 minutes once a week for 6 weeks. Each session comprises developing trust through the expression of support, affirmation, and collaboration; creating intimacy through attunement; exploring affective states; integrative processing through the creation of an autobiographical narrative; and identifying opportunities for continued exploration and resources that support the client, should that exploration become necessary.

Caregivers also complete a Meaning of Life Questionnaire and a Family Quality of Life Scale at baseline and at the end of week 6.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Health Status Unknown Psychosocial Effects of Cancer and Its Treatment

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Art Therapy

Group Type EXPERIMENTAL

psychosocial support for caregiver

Intervention Type OTHER

6 weekly 60 minute sessions

questionnaire administration

Intervention Type OTHER

Evaluated at baseline, week 1 and week 6 of art therapy

quality-of-life assessment

Intervention Type PROCEDURE

Evaluated at baseline, week 1 and week 6 of art therapy

stress management therapy

Intervention Type PROCEDURE

6 weekly 60 minute sessions

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

psychosocial support for caregiver

6 weekly 60 minute sessions

Intervention Type OTHER

questionnaire administration

Evaluated at baseline, week 1 and week 6 of art therapy

Intervention Type OTHER

quality-of-life assessment

Evaluated at baseline, week 1 and week 6 of art therapy

Intervention Type PROCEDURE

stress management therapy

6 weekly 60 minute sessions

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

DISEASE CHARACTERISTICS:

* Family caregiver identified by the patient's physician as most involved in the patient care including, but not limited to, the following:

* Mother
* Father
* Grandmother
* Grandfather
* Aunt
* Uncle
* Older sibling
* One caregiver per pediatric patient
* No caregivers who are part of an institutional system and are temporarily fulfilling the custodial role of the patient (i.e., foster parents)

PATIENT CHARACTERISTICS:

* Able to speak and read English and/or Spanish
* No uncontrolled mental health and/or physical condition

PRIOR CONCURRENT THERAPY:

* Not specified
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Cancer Institute (NCI)

NIH

Sponsor Role collaborator

City of Hope Medical Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Kate Kravits, RN, MA

Role: PRINCIPAL_INVESTIGATOR

City of Hope Comprehensive Cancer Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

City of Hope Comprehensive Cancer Center

Duarte, California, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

P30CA033572

Identifier Type: NIH

Identifier Source: secondary_id

View Link

CHNMC-08028

Identifier Type: -

Identifier Source: secondary_id

CDR0000642781

Identifier Type: REGISTRY

Identifier Source: secondary_id

08028

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.